5.00
+0(+0.00%)
Currency In USD
Address
60 Binney Street
Cambridge, MA 02142
United States of America
Phone
339 499 9300
Website
Sector
Healthcare
Industry
Biotechnology
Employees
65
First IPO Date
November 03, 2021
| Name | Title | Pay | Year Born |
| Mr. William D. Baird III, M.B.A. | Chief Executive Officer, President & Director | 954,403 | 1972 |
| Ms. Victoria Eatwell | Chief Financial Officer | 598,670 | 1986 |
| Ms. Jessica Snow | Chief Operating Officer | 603,168 | 1979 |
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
